Global Non-invasive Preimplantation Genetic Testing Market Growth 2025-2031

The global Non-invasive Preimplantation Genetic Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Non-invasive preimplantation genetic testing (NI-PGT) is a technique used in assisted reproductive technology (ART) to assess the genetic makeup of embryos before they are implanted into the uterus during in vitro fertilization (IVF).

United States market for Non-invasive Preimplantation Genetic Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Non-invasive Preimplantation Genetic Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Non-invasive Preimplantation Genetic Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Non-invasive Preimplantation Genetic Testing players cover Illumina, Thermo Fisher Scientific, Agilent, Revvity, The Cooper Companies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Non-invasive Preimplantation Genetic Testing Industry Forecast” looks at past sales and reviews total world Non-invasive Preimplantation Genetic Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Non-invasive Preimplantation Genetic Testing sales for 2025 through 2031. With Non-invasive Preimplantation Genetic Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Preimplantation Genetic Testing industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Preimplantation Genetic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Preimplantation Genetic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-invasive Preimplantation Genetic Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Preimplantation Genetic Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Preimplantation Genetic Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Preimplantation Genetic Testing market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis

Segmentation by Application:
Hospitals
Diagnostic Laboratories
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent
Revvity
The Cooper Companies
Abbott
TAKARA
QIAGEN
Vitrolife
Oxford Nanopore Technologies
Yikon Genomics
Shiva Scientific
Medicover Genetics
MedGenome
Fulgent
INVICTA GENETICS
Genea Fertility
Bioarray
GeneMind Biosciences
Unimed Biotech

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-invasive Preimplantation Genetic Testing market?

What factors are driving Non-invasive Preimplantation Genetic Testing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-invasive Preimplantation Genetic Testing market opportunities vary by end market size?

How does Non-invasive Preimplantation Genetic Testing break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.